COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis / Robert Lorenz Chua, Soeren Lukassen, Saskia Trump, Bianca P. Hennig, Daniel Wendisch, Fabian Pott, Olivia Debnath, Loreen Thürmann, Florian Kurth, Maria Theresa Völker, Julia Kazmierski, Bernd Timmermann, Sven Twardziok, Stefan Schneider, Felix Machleidt, Holger Müller-Redetzky, Melanie Maier, Alexander Krannich, Sein Schmidt, Felix Balzer, Johannes Liebig, Jennifer Loske, Norbert Suttorp, Jürgen Eils, Naveed Ishaque, Uwe Gerd Liebert, Christof von Kalle, Andreas Hocke, Martin Witzenrath, Christine Goffinet, Christian Drosten, Sven Laudi, Irina Lehmann, Christian Conrad, Leif-Erik Sander and Roland Eils
To investigate the immune response and mechanisms associated with severe coronavirus disease 2019 (COVID-19), we performed single-cell RNA sequencing on nasopharyngeal and bronchial samples from 19 clinically well-characterized patients with moderate or critical disease and from five healthy controls. We identified airway epithelial cell types and states vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In patients with COVID-19, epithelial cells showed an average three-fold increase in expression of the SARS-CoV-2 entry receptor ACE2, which correlated with interferon signals by immune cells. Compared to moderate cases, critical cases exhibited stronger interactions between epithelial and immune cells, as indicated by ligand-receptor expression profiles, and activated immune cells, including inflammatory macrophages expressing CCL2, CCL3, CCL20, CXCL1, CXCL3, CXCL10, IL8, IL1B and TNF. The transcriptional differences in critical cases compared to moderate cases likely contribute to clinical observations of heightened inflammatory tissue damage, lung injury and respiratory failure. Our data suggest that pharmacologic inhibition of the CCR1 and/or CCR5 pathways might suppress immune hyperactivation in critical COVID-19..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
26 June 2020 2020 |
---|---|
Erschienen: |
26 June 2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
---|---|
Enthalten in: |
Nature biotechnology - 38(2020), 8, Seite 970-979 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chua, Robert Lorenz [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Das PDF enthält zusätzlich einen Anhang von 15 Seiten Gesehen am 29.06.2020 |
---|
Umfang: |
10 |
---|
doi: |
10.1038/s41587-020-0602-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
170283624X |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | 170283624X | ||
003 | DE-627 | ||
005 | 20230428073809.0 | ||
007 | cr uuu---uuuuu | ||
008 | 200629s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41587-020-0602-4 |2 doi | |
035 | |a (DE-627)170283624X | ||
035 | |a (DE-599)KXP170283624X | ||
035 | |a (OCoLC)1341341754 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Chua, Robert Lorenz |e verfasserin |0 (DE-588)1212800990 |0 (DE-627)1702836665 |4 aut | |
245 | 1 | 0 | |a COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis |c Robert Lorenz Chua, Soeren Lukassen, Saskia Trump, Bianca P. Hennig, Daniel Wendisch, Fabian Pott, Olivia Debnath, Loreen Thürmann, Florian Kurth, Maria Theresa Völker, Julia Kazmierski, Bernd Timmermann, Sven Twardziok, Stefan Schneider, Felix Machleidt, Holger Müller-Redetzky, Melanie Maier, Alexander Krannich, Sein Schmidt, Felix Balzer, Johannes Liebig, Jennifer Loske, Norbert Suttorp, Jürgen Eils, Naveed Ishaque, Uwe Gerd Liebert, Christof von Kalle, Andreas Hocke, Martin Witzenrath, Christine Goffinet, Christian Drosten, Sven Laudi, Irina Lehmann, Christian Conrad, Leif-Erik Sander and Roland Eils |
264 | 1 | |c 26 June 2020 | |
300 | |a 10 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Das PDF enthält zusätzlich einen Anhang von 15 Seiten | ||
500 | |a Gesehen am 29.06.2020 | ||
520 | |a To investigate the immune response and mechanisms associated with severe coronavirus disease 2019 (COVID-19), we performed single-cell RNA sequencing on nasopharyngeal and bronchial samples from 19 clinically well-characterized patients with moderate or critical disease and from five healthy controls. We identified airway epithelial cell types and states vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In patients with COVID-19, epithelial cells showed an average three-fold increase in expression of the SARS-CoV-2 entry receptor ACE2, which correlated with interferon signals by immune cells. Compared to moderate cases, critical cases exhibited stronger interactions between epithelial and immune cells, as indicated by ligand-receptor expression profiles, and activated immune cells, including inflammatory macrophages expressing CCL2, CCL3, CCL20, CXCL1, CXCL3, CXCL10, IL8, IL1B and TNF. The transcriptional differences in critical cases compared to moderate cases likely contribute to clinical observations of heightened inflammatory tissue damage, lung injury and respiratory failure. Our data suggest that pharmacologic inhibition of the CCR1 and/or CCR5 pathways might suppress immune hyperactivation in critical COVID-19. | ||
700 | 1 | |a Lukassen, Soeren |e verfasserin |4 aut | |
700 | 1 | |a Trump, Saskia |e verfasserin |4 aut | |
700 | 1 | |a Hennig, Bianca P. |e verfasserin |4 aut | |
700 | 1 | |a Wendisch, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Pott, Fabian |e verfasserin |4 aut | |
700 | 1 | |a Debnath, Olivia |e verfasserin |4 aut | |
700 | 1 | |a Thürmann, Loreen |e verfasserin |4 aut | |
700 | 1 | |a Kurth, Florian |e verfasserin |4 aut | |
700 | 1 | |a Völker, Maria Theresa |e verfasserin |4 aut | |
700 | 1 | |a Kazmierski, Julia |e verfasserin |4 aut | |
700 | 1 | |a Timmermann, Bernd |e verfasserin |4 aut | |
700 | 1 | |a Twardziok, Sven |e verfasserin |4 aut | |
700 | 1 | |a Schneider, Stefan |e verfasserin |4 aut | |
700 | 1 | |a Machleidt, Felix |e verfasserin |4 aut | |
700 | 1 | |a Müller-Redetzky, Holger |e verfasserin |4 aut | |
700 | 1 | |a Maier, Melanie |e verfasserin |4 aut | |
700 | 1 | |a Krannich, Alexander |e verfasserin |4 aut | |
700 | 1 | |a Schmidt, Sein |e verfasserin |4 aut | |
700 | 1 | |a Balzer, Felix |e verfasserin |4 aut | |
700 | 1 | |a Liebig, Johannes |e verfasserin |4 aut | |
700 | 1 | |a Loske, Jennifer |e verfasserin |4 aut | |
700 | 1 | |a Suttorp, Norbert |e verfasserin |4 aut | |
700 | 1 | |a Eils, Jürgen |e verfasserin |0 (DE-588)1036224325 |0 (DE-627)749759399 |0 (DE-576)383714753 |4 aut | |
700 | 1 | |a Ishaque, Naveed |e verfasserin |4 aut | |
700 | 1 | |a Liebert, Uwe Gerd |d 1954- |e verfasserin |0 (DE-588)1246957280 |0 (DE-627)1780225725 |4 aut | |
700 | 1 | |a Kalle, Christof von |d 1962- |e verfasserin |0 (DE-588)1036481115 |0 (DE-627)75107926X |0 (DE-576)168957396 |4 aut | |
700 | 1 | |a Hocke, Andreas |e verfasserin |4 aut | |
700 | 1 | |a Witzenrath, Martin |e verfasserin |4 aut | |
700 | 1 | |a Goffinet, Christine |e verfasserin |4 aut | |
700 | 1 | |a Drosten, Christian |d 1972- |e verfasserin |0 (DE-588)1096365944 |0 (DE-627)856749060 |0 (DE-576)468017860 |4 aut | |
700 | 1 | |a Laudi, Sven |e verfasserin |4 aut | |
700 | 1 | |a Lehmann, Irina |e verfasserin |4 aut | |
700 | 1 | |a Conrad, Christian |e verfasserin |4 aut | |
700 | 1 | |a Sander, Leif Erik |d 1977- |e verfasserin |0 (DE-588)131666215 |0 (DE-627)51239928X |0 (DE-576)298659875 |4 aut | |
700 | 1 | |a Eils, Roland |d 1965- |e verfasserin |0 (DE-588)1020648287 |0 (DE-627)691291705 |0 (DE-576)361718195 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature biotechnology |d New York, NY : Springer Nature, 1996 |g 38(2020), 8, Seite 970-979 |h Online-Ressource |w (DE-627)30339370X |w (DE-600)1494943-X |w (DE-576)080887171 |x 1546-1696 |7 nnns |
773 | 1 | 8 | |g volume:38 |g year:2020 |g number:8 |g pages:970-979 |g extent:10 |
856 | 4 | 0 | |u https://doi.org/10.1038/s41587-020-0602-4 |x Resolving-System |x Verlag |z lizenzpflichtig |3 Volltext |
856 | 4 | 0 | |u https://www.nature.com/articles/s41587-020-0602-4 |x Verlag |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ILN_2013 | ||
912 | |a ISIL_DE-16-250 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_702 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2007 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_2026 | ||
912 | |a GBV_ILN_2027 | ||
912 | |a GBV_ILN_2064 | ||
912 | |a GBV_ILN_2068 | ||
912 | |a GBV_ILN_2190 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4323 | ||
951 | |a AR | ||
952 | |d 38 |j 2020 |e 8 |h 970-979 |g 10 | ||
980 | |2 2013 |1 01 |x DE-16-250 |b 3692033672 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 29-06-20 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd2020 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1410508463 |a wissenschaftlicher Artikel (Zeitschrift) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_36 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_10 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)166457056X |a Eils, Jürgen | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_24 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s p |0 (DE-627)1454501731 |a Kalle, Christof von | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |a pos_27 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s p |0 (DE-627)1431725609 |a Eils, Roland | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s k |0 (DE-627)1416741593 |a Institut für Medizinische Biometrie und Informatik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |a pos_36 |